Adapted Hospital Discharge Intervention: the CONNECT Pilot

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBoston Medical Center

About this trial

Hospital discharge is a dangerous time for patients: one in five will suffer an adverse event, such as a medication error, and nearly 25% will be readmitted within 30 days. This time is even more dangerous for patients with who face communication barriers, including those with non-English language preference (NELP), low health literacy, and the elderly.

The investigators will pilot a post-discharge educational intervention to reinforce written discharge instructions (known as the After Visit Summary or AVS) using a randomized controlled trial design (2:1 intervention: control). The control group will receive current standard of care discharge education which includes a nurse reviewing their AVS and an automated call in English that allows patients to numerically select types of problems/questions that are then escalated to a nurse who should return their call within a few days. The intervention group will receive the standard of care discharge education with the AVS and an additional post-discharge educational call delivered by a registered nurse or other qualified health professional with the option to have written instructions professionally translated and sent via MyChart message--if available in their preferred language.

Eligibility criteria

Qualifiers

Registered language in Epic (written or spoken) is Spanish, Haitian Creole, Portuguese, Cape Verdean, or Vietnamese

Admitted to medicine team at Boston Medical Center (BMC)

Being discharged home (to the community)

Disqualifiers

On airborne infections precautions at time of recruitment

On C diff precautions at time of recruitment

On suicide precautions at time of recruitment

Nurse report of participant displaying cognitive impairment, ongoing delirium, or aggression

Trial design

Treatments tested in this trial

  • Additional post discharge phone call

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Boston Medical Center

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator